Omnicell (OMCL) shares have been on the move this month, with the stock gaining 25% over the past month and up 17% in the past 3 months. Recent performance has caught the eye of investors, ...

Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Thursday morning. Here’s what you need to know. Omnicell beat analysts’ revenue expectations by 4.9% last ...

Ratings for Omnicell (NASDAQ:OMCL) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their ...

On Tuesday, Benchmark analysts maintained a Buy rating on Omnicell stock (NASDAQ:OMCL) with a consistent price target of $62.00 as the company approaches its earnings release scheduled for February 6.

The company continues to benefit from demand for its next-generation healthcare tech offerings. Revenue for Omnicell in its third quarter amounted to $311 million, notching the company a 10% gain in ...

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the second quarter 2025, before market open on Thursday, ...

Automating the future of patient care. That's Omnicell's goal for its new Innovation Lab, which is opening in Austin next week. Michael Garel, senior director of innovation at Omnicell, told the ...

In the latest quarter, 4 analysts provided ratings for Omnicell (NASDAQ:OMCL), showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates ...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, today announced Central Med Automation Service, a subscription-based ...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in ...